Moderna (MRNA) PT Raised to $150 at BofA Securities
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $64.97 +2.61%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham raised the price target on Moderna (NASDAQ: MRNA) to $150.00 (from $140.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades Brother Industries Ltd (6448:JP) to Neutral
- Medley Inc (4480:JP) PT Raised to JPY4,430 at Nomura/Instinet
- Mabuchi Motor Co Ltd. (6592:JP) (MBUMY) PT Raised to JPY1,730 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
